Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Summary of Product Characteristics last updated on the eMC: 21/07/2010
SPC Canesten Thrush Cream

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
  • Change to section 4.8 - Undesirable Effects
  • Change to section 5.2 - Pharmacokinetic Properties
Date of revision of text on the SPC:   02-Jul-2010
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



- To update section 4.3 (Contraindications) of the SPC to add hypersensitivity to cetostearyl alcohol

- To update section 4.8 (Undesirable effects) of the SPC to include blisters, oedema and peeling of skin using MedDRA terminology

- To update section 5.2 (Pharmacokinetic Properties) of the SPC to improve clarity of information

Updated on 28/10/2009 and displayed until 21/07/2010
Reasons for adding or updating:
  • Introduction of new pack/pack size
Date of revision of text on the SPC:   01-Oct-2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Update to include 10g tube on its own
Updated on 11/04/2007 and displayed until 28/10/2009
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   10/2006
Legal Category:   P/POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.5  2) Canesten Cream Duo changed to Canesten Cream Combi
Updated on 20/01/2006 and displayed until 11/04/2007
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 5.2 - Pharmacokinetic Properties
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 7 - Marketing Authorisation Holder
Updated on 20/01/2006 and displayed until 20/01/2006
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 5.2 - Pharmacokinetic Properties
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 7 - Marketing Authorisation Holder
Updated on 18/01/2006 and displayed until 20/01/2006
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 5.2 - Pharmacokinetic Properties
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 7 - Marketing Authorisation Holder
Updated on 06/02/2004 and displayed until 18/01/2006
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 02/09/2003 and displayed until 06/02/2004
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 (date of (partial) revision of the text
Updated on 15/10/2002 and displayed until 02/09/2003
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Updated on 23/04/2002 and displayed until 15/10/2002
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 (date of (partial) revision of the text
Updated on 13/11/2001 and displayed until 23/04/2002
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 19/09/2001 and displayed until 13/11/2001
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic Indications
  • Change to section 10 (date of (partial) revision of the text
Updated on 25/07/2001 and displayed until 19/09/2001
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 18/12/2000 and displayed until 25/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   clotrimazole